References
Key articles
Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14. Abstract
Noritz G, Davidson L, Steingass K, et al. Providing a primary care medical home for children and youth with cerebral palsy. Pediatrics. 2022 Nov 21;e2022060055.Full text Abstract
Shepherd E, Salam RA, Middleton P, et al. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2017 Aug 8;(8):CD012077.Full text Abstract
Novak I, Morgan C, Fahey M, et al. State of the Evidence Traffic Lights 2019: systematic review of interventions for preventing and treating children with cerebral palsy. Curr Neurol Neurosci Rep. 2020 Feb 21;20(2):3.Full text Abstract
Shepherd E, Salam RA, Middleton P, et al. Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews. Cochrane Database Syst Rev. 2018 Jun 20;(6):CD012409.Full text Abstract
Novak I, Morgan C, Adde L, et al. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr. 2017 Sep 1;171(9):897-907. Abstract
Delgado MR, Hirtz D, Aisen M, et al; Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Neurology. 2010 Jan 26;74(4):336-43.Full text Abstract
Fehlings D, Brown L, Harvey A, et al. Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review. Dev Med Child Neurol. 2018 Apr;60(4):356-66.Full text Abstract
Reference articles
1. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14. Abstract
2. Christine C, Dolk H, Platt MJ, et al; SCPE Collaborative Group. Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy. Dev Med Child Neurol Suppl. 2007 Feb;109:35-8. Abstract
3. Sanger TD, Delgado MR, Gaebler-Spira D, et al; Task Force on Childhood Motor Disorders. Classification and definition of disorders causing hypertonia in childhood. Pediatrics. 2003 Jan;111(1):e89-97.Full text Abstract
4. Blair E, Stanley F. Interobserver agreement in the classification of cerebral palsy. Dev Med Child Neurol. 1985 Oct;27(5):615-22. Abstract
5. Shevell MI, Dagenais L, Hall N, et al. The relationship of cerebral palsy subtype and functional motor impairment: a population-based study. Dev Med Child Neurol. 2009 Nov;51(11):872-7.Full text Abstract
6. Compagnone E, Maniglio J, Camposeo S, et al. Functional classifications for cerebral palsy: correlations between the gross motor function classification system (GMFCS), the manual ability classification system (MACS) and the communication function classification system (CFCS). Res Dev Disabil. 2014 Nov;35(11):2651-7. Abstract
7. Palisano R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997 Apr;39(4):214-23. Abstract
8. Palisano RJ, Rosenbaum P, Bartlett D, et al. Content validity of the expanded and revised Gross Motor Function Classification System. Dev Med Child Neurol. 2008 Oct;50(10):744-50.Full text Abstract
9. Eliasson AC, Krumlinde-Sundholm L, Rösblad B, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006 Jul;48(7):549-54. Abstract
10. Hidecker MJ, Paneth N, Rosenbaum PL, et al. Developing and validating the Communication Function Classification System for individuals with cerebral palsy. Dev Med Child Neurol. 2011 Aug;53(8):704-10.Full text Abstract
11. Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology. 2007 Jan 30;68(5):326-37. Abstract
12. Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol. 2002 Sep;44(9):633-40.Full text Abstract
13. Sellier E, Platt MJ, Andersen GL, et al; Surveillance of Cerebral Palsy Network. Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Dev Med Child Neurol. 2016 Jan;58(1):85-92. Abstract
14. Galea C, Mcintyre S, Smithers-Sheedy H, et al; Australian Cerebral Palsy Register Group. Cerebral palsy trends in Australia (1995-2009): a population-based observational study. Dev Med Child Neurol. 2019 Feb;61(2):186-93.Full text Abstract
15. Arnaud C, Ehlinger V, Delobel-Ayoub M, et al. Trends in prevalence and severity of pre/perinatal cerebral palsy among children born preterm from 2004 to 2010: a SCPE collaboration study. Front Neurol. 2021;12:624884.Full text Abstract
16. Pharoah PO, Cooke T. Cerebral palsy and multiple births. Arch Dis Child Fetal Neonatal Ed. 1996 Nov;75(3):F174-7.Full text Abstract
17. Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 2006 Feb 28;28(4):183-91. Abstract
18. Jahan I, Muhit M, Hardianto D, et al. Epidemiology of cerebral palsy in low- and middle-income countries: preliminary findings from an international multi-centre cerebral palsy register. Dev Med Child Neurol. 2021 May 24 [Epub ahead of print]. Abstract
19. Maenner MJ, Benedict RE, Arneson CL, et al. Children with cerebral palsy: racial disparities in functional limitations. Epidemiology. 2012 Jan;23(1):35-43.Full text Abstract
20. Noritz G, Davidson L, Steingass K, et al. Providing a primary care medical home for children and youth with cerebral palsy. Pediatrics. 2022 Nov 21;e2022060055.Full text Abstract
21. Colver AF, Gibson M, Hey EN, et al; the North of England Collaborative Cerebral Palsy Survey. Increasing rates of cerebral palsy across the severity spectrum in north-east England 1964-1993. Arch Dis Child Fetal Neonatal Ed. 2000 Jul;83(1):F7-12.Full text Abstract
22. Jacobsson B, Hagberg G. Antenatal risk factors for cerebral palsy. Best Pract Res Clin Obstet Gynaecol. 2004 Jun;18(3):425-36. Abstract
23. Kuban KC, Leviton A. Cerebral palsy. N Engl J Med. 1994 Jan 20;330(3):188-95. Abstract
24. Nelson K. Can we prevent cerebral palsy? N Engl J Med. 2003 Oct 30;349(18):1765-9. Abstract
25. Reid S, Halliday J, Ditchfield M, et al. Factor V Leiden mutation: a contributory factor for cerebral palsy? Dev Med Child Neurol. 2006 Jan;48(1):14-9. Abstract
26. Thorarensen O, Ryan S, Hunter J, et al. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol. 1997 Sep;42(3):372-5. Abstract
27. Ostrander B, Bale JF. Congenital and perinatal infections. Handb Clin Neurol. 2019;162:133-53. Abstract
28. De Groote I, Vanhaesebrouck P, Bruneel E, et al; Extremely Preterm Infants in Belgium (EPIBEL) Study Group. Outcome at 3 years of age in a population-based cohort of extremely preterm infants. Obstet Gynecol. 2007 Oct;110(4):855-64. Abstract
29. Ishii N, Kono Y, Yonemoto N, et al; Neonatal Research Network, Japan. Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics. 2013 Jul;132(1):62-71. Abstract
30. McIntyre S, Blair E, Badawi N, et al. Antecedents of cerebral palsy and perinatal death in term and late preterm singletons. Obstet Gynecol. 2013 Oct;122(4):869-77.Full text Abstract
31. Blair EM, Nelson KB. Fetal growth restriction and risk of cerebral palsy in singletons born after at least 35 weeks' gestation. Am J Obstet Gynecol. 2015 Apr;212(4):520;e1-7. Abstract
32. Croen LA, Grether JK, Curry CJ, et al. Congenital abnormalities among children with cerebral palsy: more evidence for prenatal antecedents. J Pediatr. 2001 Jun;138(6):804-10. Abstract
33. Nelson KB, Blair E. Prenatal factors in singletons with cerebral palsy born at or near term. N Engl J Med. 2015 Sep 3;373(10):946-53. Abstract
34. Nelson KB, Dambrosia JM, Ting T, et al. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med. 1996 Mar 7;334(10):613-8.Full text Abstract
35. Ronen GM, Buckley D, Penney S, et al. Long-term prognosis in children with neonatal seizures: a population-based study. Neurology. 2007 Nov 6;69(19):1816-22. Abstract
36. Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA. 2006 Oct 4;296(13):1602-8.Full text Abstract
37. Krägeloh-Mann I, Horber V. The role of magnetic resonance imaging in elucidating the athogenesis of cerebral palsy: a systematic review. Dev Med Child Neurol. 2007 Feb;49(2):144-51. Abstract
38. Nelson KB. Causative factors in cerebral palsy. Clin Obstet Gynecol. 2008 Dec;51(4):749-62. Abstract
39. Nelson KB. Is it HIE? And why that matters. Acta Paediatr. 2007 Aug;96(8):1113-4. Abstract
40. Peacock WJ. The pathophysiology of spasticity. In: The treatment of gait problems. Gage J, ed. London: MacKeith Press; 2004:38-9.
41. Koman LA, Smith BP, Shilt JS. Cerebral palsy. Lancet. 2004 May 15;363(9421):1619-31. Abstract
42. Sadowska M, Sarecka-Hujar B, Kopyta I. Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatr Dis Treat. 2020 Jun 12;16:1505-18.Full text Abstract
43. Himpens E, Van den Broeck C, Oostra A, et al. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol. 2008 May;50(5):334-40.Full text Abstract
44. Stoknes M, Andersen GL, Dahlseng MO, et al. Cerebral palsy and neonatal death in term singletons born small for gestational age. Pediatrics. 2012 Dec;130(6):e1629-35. Abstract
45. Chalak L, Kaiser J. Neonatal guideline hypoxic-ischemic encephalopathy (HIE). J Ark Med Soc. 2007 Oct;104(4):87-9. Abstract
46. Spitzmiller RE, Phillips T, Meinzen-Derr J, et al. Amplitude-integrated EEG is useful in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischemic encephalopathy: a meta-analysis. J Child Neurol. 2007 Sep;22(9):1069-78. Abstract
47. Del Río R, Ochoa C, Alarcon A, et al. Amplitude integrated electroencephalogram as a prognostic tool in neonates with hypoxic-ischemic encephalopathy: a systematic review. PLoS One. 2016;11(11):e0165744.Full text Abstract
48. Rajatileka S, Odd D, Robinson MT, et al. Variants of the EAAT2 glutamate transporter gene promoter are associated with cerebral palsy in preterm infants. Mol Neurobiol. 2017 Mar 7;55(3):2013-24.Full text Abstract
49. Jin SC, Lewis SA, Bakhtiari S, et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat Genet. 2020 Oct;52(10):1046-56. [Erratum in: Nat Genet. 2021 Mar;53(3):412.] Abstract
50. Sherlock RL, Anderson PJ, Doyle LW; Victorian Infant Collaborative Study Group. Neurodevelopmental sequelae of intraventricular haemorrhage at 8 years of age in a regional cohort of ELBW/very preterm infants. Early Hum Dev. 2005 Nov;81(11):909-16. Abstract
51. Alshaikh B, Yusuf K, Sauve R. Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis. J Perinatol. 2013 Jul;33(7):558-64.Full text Abstract
52. Cans C, McManus V, Crowley M, et al. Cerebral palsy of post-neonatal origin: characteristics and risk factors. Paediatr Perinat Epidemiol. 2004 May;18(3):214-20. Abstract
53. Collier SA, Hogue CJ. Modifiable risk factors for low birth weight and their effect on cerebral palsy and mental retardation. Matern Child Health J. 2007 Jan;11(1):65-71. Abstract
54. Burd L, Cotsonas-Hassler TM, Martsolf JT, et al. Recognition and management of fetal alcohol syndrome. Neurotoxicol Teratol. 2003 Nov-Dec;25(6):681-8. Abstract
55. Nelson KB, Chang T. Is cerebral palsy preventable? Curr Op Neurol. 2008 Apr;21(2):129-35. Abstract
56. National Institute for Health and Care Excellence (UK). Cerebral palsy in under 25s: assessment and management. January 2017 [internet publication].Full text
57. South Australia Maternal, Neonatal & Gynaecology Community of Practice. Magnesium sulphate for neuroprotection of the fetus in women at risk of preterm birth. 2020 [internet publication].Full text
58. Magee LA, De Silva DA, Sawchuck D, et al. No. 376 - Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can. 2019 Apr;41(4):505-22. Abstract
59. US Food and Drug Administration. Drug safety communications: FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies. May 2013 [internet publication].Full text
60. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010 Mar;115(3):669-71.Full text Abstract
61. Shepherd E, Salam RA, Middleton P, et al. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2017 Aug 8;(8):CD012077.Full text Abstract
62. Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004661.Full text Abstract
63. Novak I, Morgan C, Fahey M, et al. State of the Evidence Traffic Lights 2019: systematic review of interventions for preventing and treating children with cerebral palsy. Curr Neurol Neurosci Rep. 2020 Feb 21;20(2):3.Full text Abstract
64. Doyle LW, Anderson PJ, Haslam R, et al; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO4) Study Group. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo. JAMA. 2014 Sep 17;312(11):1105-13.Full text Abstract
65. Nguyen TM, Crowther CA, Wilkinson D, et al. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009395.Full text Abstract
66. Shepherd E, Salam RA, Middleton P, et al. Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews. Cochrane Database Syst Rev. 2018 Jun 20;(6):CD012409.Full text Abstract
67. Jacobs SE, Berg M, Hunt R, et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003311.Full text Abstract
68. Song J, Sun H, Xu F, et al. Recombinant human erythropoietin improves neurological outcomes in very preterm infants. Ann Neurol. 2016 Jul;80(1):24-34.Full text Abstract
69. Novak I, Morgan C, Adde L, et al. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr. 2017 Sep 1;171(9):897-907. Abstract
70. McNamara L, Scott KM, Boyd RN, et al. Consensus of physician behaviours to target for early diagnosis of cerebral palsy: a Delphi study. J Paediatr Child Health. 2021 Jul;57(7):1009-15. Abstract
71. Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004 Mar 23;62(6):851-63.Full text Abstract
72. Spittle AJ, Doyle LW, Boyd RN. A systematic review of the clinimetric properties of neuromotor assessments for preterm infants during the first year of life. Dev Med Child Neurol. 2008 Apr;50(4):254-66.Full text Abstract
73. Harel-Gadassi A, Friedlander E, Yaari M, et al. Developmental assessment of preterm infants: chronological or corrected age? Res Dev Disabil. 2018 Sep;80:35-43. Abstract
74. Nelson KB, Ellenberg JH. Children who "outgrew" cerebral palsy. Pediatrics. 1982 May;69(5):529-36. Abstract
75. Rosenbaum PL, Walter SD, Hanna SE, et al. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA. 2002 Sep 18;288(11):1357-63.Full text Abstract
76. Wu YW, Day SM, Strauss DJ, et al. Prognosis for ambulation in cerebral palsy: a population based study. Pediatrics. 2004 Nov;114(5):1264-71. Abstract
77. Einspieler C, Prechtl HF. Prechtl's assessment of general movements: a diagnostic tool for the functional assessment of the young nervous system. Ment Retard Dev Disabil Res Rev. 2005;11(1):61-7. Abstract
78. Romeo DM, Ricci D, Brogna C, et al. Use of the Hammersmith Infant Neurological Examination in infants with cerebral palsy: a critical review of the literature. Dev Med Child Neurol. 2016 Mar;58(3):240-5.Full text Abstract
79. Haataja L, Mercuri E, Regev R, et al. Optimality score for the neurologic examination of the infant at 12 and 18 months of age. J Pediatr. 1999 Aug;135(2 pt 1):153-61. Abstract
80. Byrne R, Noritz G, Maitre NL, et al. Implementation of early diagnosis and intervention guidelines for cerebral palsy in a high-risk infant follow-up clinic. Pediatr Neurol. 2017 Nov;76:66-71.Full text Abstract
81. Voress JK, Maddox T, Hammill DD. Developmental assessment of young children. 2nd ed. London: Pearson Clinical Assessments; 2012.
82. Bleck EE. Locomotor prognosis in cerebral palsy. Dev Med Child Neurol. 1975 Feb;17(1):18-25. Abstract
83. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 Feb;67(2):206-7. Abstract
84. Fowler EG, Staudt LA, Greenberg M, et al. Selective Control Assessment of the Lower Extremity (SCALE): development, validation, and interrater reliability of a clinical tool for patients with cerebral palsy. Dev Med Child Neurol. 2009 Aug;51(8):607-14. Abstract
85. Hägglund G, Lauge-Pedersen H, Wagner P. Characteristics of children with hip displacement in cerebral palsy. BMC Musculoskelet Disord. 2007 Oct 26;8:101.Full text Abstract
86. Korzeniewski SJ, Birbeck G, DeLano MC, et al. A systematic review of neuroimaging for cerebral palsy. J Child Neurol. 2008 Feb;23(2):216-27. Abstract
87. Hope TA, Gregson PH, Linney NC, et al. Selecting and assessing quantitative early ultrasound texture measures for their association with cerebral palsy. IEEE Trans Med Imaging. 2008 Feb;27(2):228-36. Abstract
88. Elias ER. Genetic evaluation in the newborn. Neoreviews. 2003 Oct;4(10):277-82.
89. Starkowski LA. The unusual suspects: genetic metabolic disorders in the newborn. Highlights of the National Association of Neonatal Nurses 23rd Annual Conference. San Diego, CA, 26-29 Sep 2007.
90. Australasian Academy of Cerebral Palsy and Developmental Medicine. Australian hip surveillance guidelines for children with cerebral palsy. 2020 [internet publication].Full text
91. Simon AL Jr, Presedo A, Ilharreborde B, et al. Can turned inward patella predict an excess of femoral anteversion during gait in spastic diplegic children? J Pediatr Orthop. 2014 Jun;34(4):405-10. Abstract
92. NINDS Common Data Elements. Cerebral palsy. 2021 [internet publication].Full text
93. Feldman AB, Haley SM, Coryell J. Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther. 1990 Oct;70(10):602-10. Abstract
94. Thomas SS, Buckon CE, Phillips DS, et al. Interobserver reliability of the gross motor performance measure: preliminary results. Dev Med Child Neurol. 2001 Feb;43(2):97-102. Abstract
95. Koman LA, Mooney JF, Smith BP, et al. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop. 1994 May-Jun;14(3):299-303. Abstract
96. Barry MJ, Van Swearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol. 1999 Jun;41(6):404-11. Abstract
97. Graham HK, Harvey A, Rodda J , et al. The Functional Mobility Scale (FMS). J Pediatr Orthop. 2004 Sep-Oct;24(5):514-20. Abstract
98. Fehlings D, Switzer L, Jethwa A, et al. Hypertonia assessment tool (HAT): user manual. 1st ed. Toronto: Bloorview Kids Rehab; 2010.
99. Jethwa A, Mink J, Macarthur C, et al. Development of the hypertonia assessment tool (HAT): a discriminative tool for hypertonia in children. Dev Med Child Neurol. 2010 May;52(5):e83-7.Full text Abstract
100. Mulcahey MJ, Slavin MD, Ni P, et al. Computerized adaptive tests detect change following orthopaedic surgery in youth with cerebral palsy. J Bone Joint Surg Am. 2015 Sep 16;97(18):1482-94. Abstract
101. Lemmens RJ, Timmermans AA, Janssen-Potten YJ, et al. Valid and reliable instruments for arm-hand assessment at ICF activity level in persons with hemiplegia: a systematic review. BMC Neurol. 2012 Apr 12;12:21.Full text Abstract
102. Wagner LV, Davids JR. Assessment tools and classification systems used for the upper extremity in children with cerebral palsy. Clin Orthop Relat Res. 2012 May;470(5):1257-71.Full text Abstract
103. McConnell K, Johnston L, Kerr C. Upper limb function and deformity in cerebral palsy: a review of classification systems. Dev Med Child Neurol. 2011 Sep;53(9):799-805. Abstract
104. Lipkin PH, Macias MM, Council on Children with Disabilities, Section on Developmental and Behavioral Pediatrics. Promoting optimal development: identifying infants and young children with developmental disorders through developmental surveillance and screening. Pediatrics. 2020 Jan;145(1):e20193449.Full text Abstract
105. Centers for Disease Control and Prevention. Screening and diagnosis of cerebral palsy. 31 December 2020 [internet publication].Full text
106. Morris C. The definition and classification of cerebral palsy. Dev Med Child Neurol. 2007 Feb;49(s109):1-44.Full text Abstract
107. National Institute for Health and Care Excellence (UK). Cerebral palsy in adults. January 2019 [internet publication].Full text
108. Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016 Jun 28;353:i2016.Full text Abstract
109. Law MC, Darrah J, Pollock N, et al. Focus on function: a cluster, randomized controlled trial comparing child- versus context-focused intervention for young children with cerebral palsy. Dev Med Child Neurol. 2011 Jul;53(7):621-9.Full text Abstract
110. Delgado MR, Hirtz D, Aisen M, et al; Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Neurology. 2010 Jan 26;74(4):336-43.Full text Abstract
111. Heinen F, Desloovere K, Schroeder AF, et al. The updated European Consensus 2009 on the use of botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol. 2010 Jan;14(1):45-66. Abstract
112. Love SC, Novak I, Kentish M, et al. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. Eur J Neurol. 2010 Aug;17 suppl 2:9-37. Abstract
113. Hoare BJ, Wallen MA, Imms C, et al. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003469.Full text Abstract
114. Blumetti FC, Belloti JC, Tamaoki MJ, et al. Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy. Cochrane Database Syst Rev. 2019 Oct 8;(10):CD001408.Full text Abstract
115. Zafonte RD, Munin MC. Phenol and alcohol blocks for the treatment of spasticity. Phys Med Rehabil Clin N Am. 2001 Nov;12(4):817-32. Abstract
116. McLaughlin M, Bjornson K, Temkin N, et al. Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials. Dev Med Child Neurol. 2002 Jan;44(1):17-25. Abstract
117. Daunter AK, Kratz AL, Hurvitz EA. Long-term impact of childhood selective dorsal rhizotomy on pain, fatigue, and function: a case-control study. Dev Med Child Neurol. 2017 Jun 15;59(10):1089-95.Full text Abstract
118. Buizer AI, Martens BHM, Grandbois van Ravenhorst C, et al. Effect of continuous intrathecal baclofen therapy in children: a systematic review. Dev Med Child Neurol. 2019 Feb;61(2):128-34.Full text Abstract
119. Hasnat MJ, Rice JE. Intrathecal baclofen for treating spasticity in children with cerebral palsy. Cochrane Database Syst Rev. 2015 Nov 13;(11):CD004552.Full text Abstract
120. Blackmore AM, Boettcher-Hunt E, Jordan M, et al. A systematic review of the effects of casting on equinus in children with cerebral palsy: an evidence report of the AACPDM. Dev Med Child Neurol. 2007 Oct;49(10):781-90. Abstract
121. Halanski M, Noonan KJ. Cast and splint immobilization: complications. J Am Acad Orthop Surg. 2008 Jan;16(1):30-40. Abstract
122. Fehlings D, Brown L, Harvey A, et al. Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review. Dev Med Child Neurol. 2018 Apr;60(4):356-66.Full text Abstract
123. Harvey AR, Baker LB, Reddihough DS, et al. Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database Syst Rev. 2018 May 15;(5):CD012430.Full text Abstract
124. Sanger TD, Kukke SN, Sherman-Levine S. Botulinum toxin type B improves the speed of reaching in children with cerebral palsy and arm dystonia: an open-label, dose-escalation pilot study. J Child Neurol. 2007 Jan;22(1):116-22. Abstract
125. Yi YG, Kim K, Yi Y, et al. Botulinum toxin type A injection for cervical dystonia in adults with dyskinetic cerebral palsy. Toxins (Basel). 2018 May 16;10(5):203.Full text Abstract
126. Albright AL, Barry MJ, et.al. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol. 2001 Oct;43(10):652-7. Abstract
127. Eek MN, Olsson K, Lindh K, et al. Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity. Dev Med Child Neurol. 2017 Nov 17;60(1):94-9. Abstract
128. Bonouvrié LA, Becher JG, Vles JSH, et al. The effect of intrathecal baclofen in dyskinetic cerebral palsy: the IDYS trial. Ann Neurol. 2019 Jul;86(1):79-90.Full text Abstract
129. Sanger TD. Deep brain stimulation for cerebral palsy: where are we now? Dev Med Child Neurol. 2020 Jan;62(1):28-33.Full text Abstract
130. Krauss JK, Loher TJ, Weigel R, et al. Chronic stimulation of the globus pallidus internus for treatment of non-dYT1 generalized dystonia and choreoathetosis: 2-year follow up. J Neurosurg. 2003 Apr;98(4):785-92. Abstract
131. Masson R, Pagliano E, Baranello G. Efficacy of oral pharmacological treatments in dyskinetic cerebral palsy: a systematic review. Dev Med Child Neurol. 2017 Dec;59(12):1237-48.Full text Abstract
132. Verschuren O, Peterson MD, Balemans AC, et al. Exercise and physical activity recommendations for people with cerebral palsy. Dev Med Child Neurol. 2016 Aug;58(8):798-808.Full text Abstract
133. Gordon AM, Schneider JA, Chinnan A, et al. Efficacy of a hand-arm bimanual intensive therapy (HABIT) in children with hemiplegic cerebral palsy: a randomized control trial. Dev Med Child Neurol. 2007 Nov;49(11):830-8. Abstract
134. Fowler EG, Kolobe TH, Damiano DL, et al; Section on Pediatrics Research Summit Participants; Section on Pediatrics Research Committee Task Force. Promotion of physical fitness and prevention of secondary conditions for children with cerebral palsy: section on pediatrics research summit proceedings. Phys Ther. 2007 Nov;87(11):1495-510.Full text Abstract
135. Demuth SK, Knutson LM, Fowler EG. The PEDALS stationary cycling intervention and health-related quality of life in children with cerebral palsy: a randomized controlled trial. Dev Med Child Neurol. 2012 Jul;54(7):654-61. Abstract
136. Franki I, Desloovere K, De Cat J, et al. The evidence-base for conceptual approaches and additional therapies targeting lower limb function in children with cerebral palsy: a systematic review using the ICF as a framework. J Rehabil Med. 2012 May;44(5):396-405. Abstract
137. Ryan JM, Cassidy EE, Noorduyn SG, et al. Exercise interventions for cerebral palsy. Cochrane Database Syst Rev. 2017 Jun 11;(6):CD011660.Full text Abstract
138. Bryant E, Pountney T, Williams H, et al. Can a six-week exercise intervention improve gross motor function for non-ambulant children with cerebral palsy? A pilot randomized controlled trial. Clin Rehabil. 2013 Feb;27(2):150-9. Abstract
139. Hoare BJ, Wallen MA, Thorley MN, et al. Constraint-induced movement therapy in children with unilateral cerebral palsy. Cochrane Database Syst Rev. 2019 Apr 1;(4):CD004149.Full text Abstract
140. Maitre NL, Jeanvoine A, Yoder PJ, et al; BBOP Group. Kinematic and somatosensory gains in infants with cerebral palsy after a multi-component upper-extremity intervention: a randomized controlled trial. Brain Topogr. 2020 Nov;33(6):751-66. Abstract
141. Chorna O, Heathcock J, Key A, et al. Early childhood constraint therapy for sensory/motor impairment in cerebral palsy: a randomised clinical trial protocol. BMJ Open. 2015 Dec 7;5(12):e010212.Full text Abstract
142. Chiu HC, Ada L, Bania TA. Mechanically assisted walking training for walking, participation, and quality of life in children with cerebral palsy. Cochrane Database Syst Rev. 2020 Nov 18;(11):CD013114.Full text Abstract
143. Rogers A, Furler BL, Brinks S, et al. A systematic review of the effectiveness of aerobic exercise interventions for children with cerebral palsy: an AACPDM evidence report. Dev Med Child Neurol. 2008 Nov;50(11):808-14.Full text Abstract
144. Slaman J, van den Berg-Emons HJ, van Meeteren J, et al. A lifestyle intervention improves fatigue, mental health and social support among adolescents and young adults with cerebral palsy: focus on mediating effects. Clin Rehabil. 2015 Jul;29(7):717-27. Abstract
145. Slaman J, Roebroeck M, Dallmijer A, et al. Can a lifestyle intervention programme improve physical behaviour among adolescents and young adults with spastic cerebral palsy? A randomized controlled trial. Dev Med Child Neurol. 2015 Feb;57(2):159-66.Full text Abstract
146. Colver A, Rapp M, Eisemann N, et al. Self-reported quality of life of adolescents with cerebral palsy: a cross-sectional and longitudinal analysis. Lancet. 2015 Feb 21;385(9969):705-16.Full text Abstract
147. Michelsen SI, Flachs EM, Damsgaard MT, et al. European study of frequency of participation of adolescents with and without cerebral palsy. Eur J Paediatr Neurol. 2014 May;18(3):282-94.Full text Abstract
148. Ryan JM, Hensey O, McLoughlin B, et al. Reduced moderate-to-vigorous physical activity and increased sedentary behavior are associated with elevated blood pressure values in children with cerebral palsy. Phys Ther. 2014 Aug;94(8):1144-53.Full text Abstract
149. Lintanf M, Bourseul JS, Houx L, et al. Effect of ankle-foot orthoses on gait, balance and gross motor function in children with cerebral palsy: a systematic review and meta-analysis. Clin Rehabil. 2018 Sep;32(9):1175-88.Full text Abstract
150. Ries AJ, Novacheck TF, Schwartz MH. The efficacy of ankle-foot orthoses on improving the gait of children with diplegic cerebral palsy: a multiple outcome analysis. PM R. 2015 Sep;7(9):922-9. Abstract
151. Jackman M, Novak I, Lannin N. Effectiveness of hand splints in children with cerebral palsy: a systematic review with meta-analysis. Dev Med Child Neurol. 2014 Feb;56(2):138-47.Full text Abstract
152. Betancourt JP, Eleeh P, Stark S, et al. Impact of ankle-foot orthosis on gait efficiency in ambulatory children with cerebral palsy: a systematic review and meta-analysis. Am J Phys Med Rehabil. 2019 Sep;98(9):759-70. Abstract
153. Rodby-Bousquet E, Paleg G, Casey J, et al. Physical risk factors influencing wheeled mobility in children with cerebral palsy: a cross-sectional study. BMC Pediatr. 2016 Oct 10;16(1):165.Full text Abstract
154. Kristoffersson E, Dahlgren Sandberg A, Holck P. Communication ability and communication methods in children with cerebral palsy Dev Med Child Neurol. 2020 Aug;62(8):933-8.Full text Abstract
155. Light J, McNaughton D, Beukelman D, et al. Challenges and opportunities in augmentative and alternative communication: research and technology development to enhance communication and participation for individuals with complex communication needs. Augment Altern Commun. 2019 Mar;35(1):1-12. Abstract
156. Howcroft J, Fehlings D, Wright V, et al. A comparison of solo and multiplayer active videogame play in children with unilateral cerebral palsy. Games Health J. 2012 Aug;1(4):287-93. Abstract
157. Bonnechère B, Jansen B, Omelina L, et al. Can serious games be incorporated with conventional treatment of children with cerebral palsy? A review. Res Dev Disabil. 2014 Aug;35(8):1899-913. Abstract
158. Chen Y, Fanchiang HD, Howard A. Effectiveness of virtual reality in children with cerebral palsy: a systematic review and meta-analysis of randomized controlled trials. Phys Ther. 2018 Jan 1;98(1):63-77.Full text Abstract
159. MacIntosh A, Desailly E, Vignais N, et al. A biofeedback-enhanced therapeutic exercise video game intervention for young people with cerebral palsy: a randomized single-case experimental design feasibility study. PLoS One. 2020;15(6):e0234767.Full text Abstract
160. Lundy CT, Doherty GM, Fairhurst CB. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy. Dev Med Child Neurol. 2009 Sep;51(9):705-10.Full text Abstract
161. Graham HK, Boyd R, Carlin JB, et al. Does botulinum toxin A combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial. J Bone Joint Surg Am. 2008 Jan;90(1):23-33. Abstract
162. Multani I, Manji J, Tang MJ, et al. Sarcopenia, cerebral palsy, and botulinum toxin type A. JBJS Rev. 2019 Aug;7(8):e4.Full text Abstract
163. Sätilä H. Over 25 years of pediatric botulinum toxin treatments: what have we learned from injection techniques, doses, dilutions, and recovery of repeated injections? Toxins (Basel). 2020 Jul 6;12(7):440.Full text Abstract
164. Naumann M, Boo LM, Ackerman AH, et al. Immunogenicity of botulinum toxins. J Neural Transm (Vienna). 2013 Feb;120(2):275-90.Full text Abstract
165. Tilton AH. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. J Child Neurol. 2003 Sep;18 suppl 1:S50-66. Abstract
166. Gooch JL, Patton CP. Combining botulinum toxin and phenol to manage spasticity in children. Arch Phys Med Rehabil. 2004 Jul;85(7):1121-4. Abstract
167. Kraus T, Gegenleitner K, Svehlik M, et al. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy. Eur J Paediatr Neurol. 2017 Feb 11;21(3):565-9. Abstract
168. Kolaski K, Logan LR. A review of the complications of intrathecal baclofen in patients with cerebral palsy. NeuroRehabilitation. 2007;22(5):383-95. Abstract
169. Ridley R, Rawlins PK. Intrathecal baclofen therapy: ten steps towards best practice. J Neurosci Nurs. 2006 Apr;38(2):72-82. Abstract
170. Campbell WM, Ferrel A. Long term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol. 2002 Oct;44(10):660-5. Abstract
171. Dario A, Scamoni C, Picano M, et al. The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation. 2005 Jan;8(1):36-9. Abstract
172. Bayhan IA, P Sees J, Nishnianidze T, et al. Infection as a complication of intrathecal baclofen treatment in children with cerebral palsy. J Pediatr Orthop. 2016 Apr-May;36(3):305-9. Abstract
173. Coffey RJ, Edgar TS, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil. 2002 Jun;83(6):735-41. Abstract
174. de Assis Gondim F, Lopes AC, et al. Gastric emptying and gastrointestinal motility abnormalities after spinal cord injury. Arch Phys Med Rehabil. 2002 Oct;83(10):1479. Abstract
175. Motta F, Buonaguro V, Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg. 2007 Jul;107(1 suppl):32-5. Abstract
176. Gooch JL, Oberg WA, et al. Complications of intrathecal baclofen pumps in children. Ped Neurosurg. 2003 Jul;39(1):1-6. Abstract
177. Dawes WJ, Drake JM, Fehlings D. Microfracture of a baclofen pump catheter with intermittent under- and overdose. Pediatr Neurosurg. 2003 Sep;39(3):144-8. Abstract
178. Wheelwright M, Selvey PJ, Steinbok P, et al. Systematic review of spinal deformities following multi-level selective dorsal rhizotomy. Childs Nerv Syst. 2020 May;36(5):1025-35. Abstract
179. Veerbeek BE, Lamberts RP, Fieggen AG, et al. A long-term follow-up study of spinal abnormalities and pain in adults with cerebral palsy and spastic diplegia more than 25 years after selective dorsal rhizotomy. J Neurosurg Spine. 2020 Oct 16;1-8. Abstract
180. Lundkvist Josenby A, Westbom L. No support that early selective dorsal rhizotomy increase frequency of scoliosis and spinal pain - a longitudinal population-based register study from four to 25 years of age. BMC Musculoskelet Disord. 2020 Nov 27;21(1):782.Full text Abstract
181. Tedroff K, Hägglund G, Miller F. Long-term effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2020 May;62(5):554-62.Full text Abstract
182. Õunpuu S, Solomito M, Bell K, et al. Long-term outcomes after multilevel surgery including rectus femoris, hamstring and gastrocnemius procedures in children with cerebral palsy. Gait Posture. 2015 Sep;42(3):365-72. Abstract
183. Dreher T, Thomason P, Švehlík M, et al. Long-term development of gait after multilevel surgery in children with cerebral palsy: a multicentre cohort study. Dev Med Child Neurol. 2018 Jan;60(1):88-93.Full text Abstract
184. Larnert P, Risto O, Hägglund G, et al. Hip displacement in relation to age and gross motor function in children with cerebral palsy. J Child Orthop. 2014 Mar;8(2):129-34.Full text Abstract
185. Hägglund G, Andersson S, Düppe H, et al. Prevention of dislocation of the hip in children with cerebral palsy: the first ten years of a population-based prevention programme. J Bone Joint Surg Br. 2005 Jan;87(1):95-101. Abstract
186. DiFazio R, Shore B, Vessey JA, et al. Effect of hip reconstructive surgery on health-related quality of life of non-ambulatory children with cerebral palsy. J Bone Joint Surg Am. 2016 Jul 20;98(14):1190-8. Abstract
187. Dartnell J, Gough M, Paterson JM, et al. Proximal femoral resection without post-operative traction for the painful dislocated hip in young patients with cerebral palsy: a review of 79 cases. Bone Joint J. 2014 May;96-B(5):701-6. Abstract
188. Dartnell J, Paterson JM, Magill N, et al. Proximal femoral resection for the painful dislocated hip in cerebral palsy: does indomethacin prevent heterotopic ossification? J Pediatr Orthop. 2014 Apr-May;34(3):295-9. Abstract
189. Hogan KA, Blake M, Gross RH. Subtrochanteric valgus osteotomy for chronically dislocated, painful spastic hips. J Bone Joint Surg Am. 2006 Dec;88(12):2624-31. Abstract
190. Rutz E, McCarthy J, Shore BJ, et al. Indications for gastrocsoleus lengthening in ambulatory children with cerebral palsy: a Delphi consensus study. J Child Orthop. 2020 Oct 1;14(5):405-14.Full text Abstract
191. Drefus LC, Buckland MA, Backus SI, et al. The functional effect of a distal rectus femoris tenotomy in adults with cerebral palsy. Gait Posture. 2014;40(1):145-9. Abstract
192. Stout JL, Gage JR, Schwartz MH, et al. Distal femoral extension osteotomy and patellar tendon advancement to treat persistent crouch gait in cerebral palsy. J Bone Joint Surg Am. 2008 Nov;90(11):2470-84. Abstract
193. Novacheck TF, Stout JL, Gage JR, et al. Distal femoral extension osteotomy and patellar tendon advancement to treat persistent crouch gait in cerebral palsy. Surgical technique. J Bone Joint Surg Am. 2009 Oct 1;91 suppl 2:271-86. Abstract
194. Healy MT, Schwartz MH, Stout JL, et al. Is simultaneous hamstring lengthening necessary when performing distal femoral extension osteotomy and patellar tendon advancement? Gait Posture. 2011 Jan;33(1):1-5. Abstract
195. Boyer ER, Stout JL, Laine JC, et al. Long-term outcomes of distal femoral extension osteotomy and patellar tendon advancement in individuals with cerebral palsy. J Bone Joint Surg Am. 2018 Jan 3;100(1):31-41. Abstract
196. Funk S, Lovejoy S, Mencio G, et al. Rigid instrumentation for neuromuscular scoliosis improves deformity correction without increasing complications. Spine (Phila Pa 1976). 2016 Jan;41(1):46-52. Abstract
197. National Center for Complementary and Integrative Health. Are you considering a complementary health approach? September 2016 [internet publication].Full text
198. ResearchGate. Complementary and alternative medicine in cerebral palsy. October 2020 [internet publication].
199. Collet JP, Vanasse M, Marois P, et al. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. HBO-CP Research Group. Lancet. 2001 Feb 24;357(9256):582-6. Abstract
200. Dali C, Hansen FJ, Pedersen SA, et al. Threshold electrical stimulation (TES) in ambulant children with CP: a randomized double-blind placebo-controlled clinical trial. Dev Med Child Neurol. 2002 Jun;44(6):364-9.Full text Abstract
201. Wyatt K, Edwards V, Franck L, et al. Cranial osteopathy for children with cerebral palsy: a randomised controlled trial. Arch Dis Child. 2011 Jun;96(6):505-12.Full text Abstract
202. Fairhurst C, Kumar R, Checketts D, et al. Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial. Dev Med Child Neurol. 2020 Sep;62(9):1031-9.Full text Abstract
203. Nielsen S, Murnion B, Campbell G, et al. Cannabinoids for the treatment of spasticity. Dev Med Child Neurol. 2019 Jun;61(6):631-8.Full text Abstract
204. ClinicalTrials.gov. Full-spectrum medical cannabis for treatment of spasticity in patients with severe forms of cerebral palsy (HemPhar). 18 November 2020 [internet publication].Full text
205. Capio CM, Sit CH, Abernethy B, et al. Physical activity measurement instruments for children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2010 Oct;52(10):908-16. Abstract
206. Butler JM, Scianni A, Ada L. Effect of cardiorespiratory training on aerobic fitness and carryover to activity in children with cerebral palsy: a systematic review. Int J Rehabil Res. 2010 Jun;33(2):97-103. Abstract
207. Van Wely L, Balemans AC, Becher JG, et al. The effectiveness of a physical activity stimulation programme for children with cerebral palsy on social participation, self-perception and quality of life: a randomized controlled trial. Clin Rehabil. 2014 Oct;28(10):972-82. Abstract
208. Scheinberg A, Hall K, Lam LT, et al. Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study. J Paediatr Child Health. 2006 Nov;42(11):715-20. Abstract
209. Edgar TS. Oral pharmacotherapy of childhood movement disorders. J Child Neurol 2003 Sep;18 suppl 1:S40-9. Abstract
210. Romantsik O, Bruschettini M, Moreira A, et al. Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants. Cochrane Database Syst Rev. 2019 Sep 24;(9):CD013201.Full text Abstract
211. Bruschettini M, Romantsik O, Moreira A, et al. Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants. Cochrane Database Syst Rev. 2020 Aug 19;(8):CD013202.Full text Abstract
212. ClinicalTrials.gov. Safety and effectiveness of banked cord blood or bone marrow stem cells in children with cerebral palsy (CP). (ACT for CP). 15 May 2020 [internet publication].Full text
213. ClinicalTrials.gov. Bone marrow-derived stem cell transplantation for the treatment of cerebral palsy. 17 March 2020 [internet publication].Full text
214. ClinicalTrials.gov. Stem cells in umbilical blood infusion for CP (SCUBI-CP). 20 January 2021 [internet publication].Full text
215. ClinicalTrials.gov. Allogenic cord blood transfusion in patients with cerebral palsy. 17 March 2021 [internet publication].Full text
216. Hameed MQ, Dhamne SC, Gersner R, et al. Transcranial magnetic and direct current stimulation in children. Curr Neurol Neurosci Rep. 2017 Feb;17(2):11.Full text Abstract
217. Kirton A, Andersen J, Herrero M, et al. Brain stimulation and constraint for perinatal stroke hemiparesis: The PLASTIC CHAMPS Trial. Neurology. 2016 May 3;86(18):1659-67. Abstract
218. Fleming MK, Theologis T, Buckingham R, et al. Transcranial direct current stimulation for promoting motor function in cerebral palsy: a review. J Neuroeng Rehabil. 2018 Dec 20;15(1):121.Full text Abstract
219. Grecco LA, Duarte NA, Zanon N, et al. Effect of a single session of transcranial direct-current stimulation on balance and spatiotemporal gait variables in children with cerebral palsy: a randomized sham-controlled study. Braz J Phys Ther. 2014 Sep-Oct;18(5):419-27.Full text Abstract
220. Flamand VH, Schneider C. Noninvasive and painless magnetic stimulation of nerves improved brain motor function and mobility in a cerebral palsy case. Arch Phys Med Rehabil. 2014 Oct;95(10):1984-90. Abstract
221. Flamand VH, Beaulieu LD, Nadeau L, et al. Peripheral magnetic stimulation to decrease spasticity in cerebral palsy. Pediatr Neurol. 2012 Nov;47(5):345-8. Abstract
222. Casey LM. Nutritional evaluation of the neurologically impaired child. Paediatr Child Health. 2020 Mar;25(2):125-6. Abstract
223. Magee L, Sawchuck D, Synnes A, et al; Magnesium Sulphate for Fetal Neuroprotection Consensus Committee; Maternal Fetal Medicine Committee. SOGC clinical practice guideline: magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can. 2011 May;33(5):516-29. Abstract
224. Gibson N, Blackmore AM, Chang AB, et al. Prevention and management of respiratory disease in young people with cerebral palsy: consensus statement. Dev Med Child Neurol. 2021 Feb;63(2):172-82.Full text Abstract
225. Sakzewski L, Boyd R, Ziviani J. Clinimetric properties of participation measures for 5- to 13-year-old children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2007 Mar;49(3):232-40. Abstract
226. Agency for Healthcare Research and Quality. Interventions for feeding and nutrition in cerebral palsy: comparative effectiveness review no. 94. Mar 2013 [internet publication].Full text Abstract
227. Strauss D, Shavelle R, Reynolds R. Survival in cerebral palsy in the last 20 years: signs of improvement? Dev Med Child Neurol. 2007 Feb;49(2):86-92. Abstract
228. Strauss D, Brooks, J, Rosenbaum L. Life expectancy in cerebral palsy: an update. Dev Med Child Neurol. 2008 Jul;50(7):487-93. Abstract
229. Ryan JM, Allen E, Gormley J, et al. The risk, burden, and management of non-communicable diseases in cerebral palsy: a scoping review. Dev Med Child Neurol. 2018 Mar 24;60(8):753-64.Full text Abstract
230. Liptak GS. Health and well being of adults with cerebral palsy. Curr Op Neurol. 2008 Apr;21(2):136-42. Abstract
231. Sienko SE. An exploratory study investigating the multidimensional factors impacting the health and well-being of young adults with cerebral palsy. Disabil Rehabil. 2018 Mar 9;40(6):660-6. Abstract
232. Samson-Fang L, Bell KL. Assessment of growth and nutrition in children with cerebral palsy. Eur J Clin Nutr. 2013 Dec;67 suppl 2:S5-8.Full text Abstract
233. Whittingham K, Sanders M, McKinlay L, et al. Interventions to reduce behavioral problems in children with cerebral palsy: an RCT. Pediatrics. 2014 May;133(5):e1249-57. Abstract
234. Jones MW, Morgan E, Shelton JE. Primary care of the child with cerebral palsy: a review of systems (part II). J Pediatr Health Care. 2007 Jul-Aug;21(4):226-37. Abstract
235. Spiroglou K, Xinias I, Karatzas N, et al. Gastric emptying in children with cerebral palsy and gastroesophageal reflux. Pediatr Neurol. 2004 Sep;31(3):177-82. Abstract
236. Galland BC, Elder DE, Taylor BJ. Interventions with a sleep outcome for children with cerebral palsy or a post-traumatic brain injury: a systematic review. Sleep Med Rev. 2012 Dec;16(6):561-73. Abstract
237. Castiglia P. Dietary supplements for children. J Pediatr Health Care. 2000 Nov-Dec;14(6):309-11. Abstract
238. Speyer R, Cordier R, Kim JH, et al. Prevalence of drooling, swallowing, and feeding problems in cerebral palsy across the lifespan: a systematic review and meta-analyses. Dev Med Child Neurol. 2019 Nov;61(11):1249-58.Full text Abstract
239. Eiland LS. Glycopyrrolate for chronic drooling in children. Clin Ther. 2012 Apr;34(4):735-42. Abstract
240. Mato A, Limeres J, Tomás I, et al. Management of drooling in disabled patients with scopolamine patches. Br J Clin Pharmacol. 2010 Jun;69(6):684-8.Full text Abstract
241. Reddihough D, Erasmus CE, Johnson H, et al. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. Eur J Neurol. 2010 Aug;17 suppl 2:109-21. Abstract
242. Rodwell K, Edwards P, Ware RS, et al. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review. Dev Med Child Neurol. 2012 Nov;54(11):977-87. Abstract
243. Khadivi E, Ashraf Zadeh F, Bakhshaee M, et al. Bilateral submandibular duct rerouting: Assessment of results on drooling in cerebral palsy cases. Auris Nasus Larynx. 2013 Oct;40(5):487-90. Abstract
244. Stern Y, Feinmesser R, Collins M, et al. Bilateral submandibular gland excision with parotid duct ligation for treatment of sialorrhea in children: long-term results. Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):801-3.Full text Abstract
245. National Institute for Health and Care Excellence (UK). Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide. 14 February 2017 [internet publication].Full text
246. Carranza-del Rio J, Clegg NJ, Moore A, et al. Use of trihexyphenidyl in children with cerebral palsy. Pediatr Neurol. 2011 Mar;44(3):202-6. Abstract
247. Fehlings D, Switzer L, Agarwal P, et al. Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review. Dev Med Child Neurol. 2012 Feb;54(2):106-16.Full text Abstract
248. Hurley T, Zareen Z, Stewart P, et al. Bisphosphonate use in children with cerebral palsy. Cochrane Database Syst Rev. 2021 Jul 5;(7):CD012756.Full text Abstract
249. Duruflé A, Pétrilli S, Le Guiet JL, et. al. Cervical spondylotic myelopathy in athetoid cerebral palsy patients: about five cases. Joint Bone Spine. 2005 May;72(3):270-4. Abstract
250. Ho H, Park-Ko I. Spinal cord injury secondary to cervical disc herniation in ambulatory patients with cerebral palsy. Spinal Cord. 1998 Apr;36(4):288-92. Abstract
Use of this content is subject to our disclaimer